News
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...
Hims & Hers Health shares have surged 32.4% since Tuesday's session open. The stock is gaining following a standout ...
Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives ...
The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...
The decline in Hims & Hers’ stock price comes as the market reacts to the potential dilution of shares resulting from the ...
Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.
Hims & Hers management's 2030 guidance includes $6.5 billion in revenue and $1.3 billion in adjusted EBITDA. Read why HIMS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results